Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterol O-acyltransferase 1 (SOAT1), also known as acyl-CoA:cholesterol acyltransferase 1 (ACAT1), is an intracellular enzyme that catalyzes the formation of cholesteryl esters from cholesterol and fatty acyl-CoA. This reaction is crucial for cellular cholesterol homeostasis, as it converts free cholesterol into a storage form—cholesteryl ester—that accumulates in lipid droplets within cells. SOAT1 plays a central role in cholesterol metabolism, atherosclerosis development, and may be a therapeutic target for various diseases.
SOAT1 catalyzes the formation of cholesteryl esters from cholesterol and fatty acyl-CoA, regulating intracellular free cholesterol levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterol O-acyltransferase 1 (SOAT1).